Consensus Ocugen, Inc.

Equities

OCGN

US67577C1053

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
1.28 ^USD	+8.47%		-3.03%	+122.61%

04-22	Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating	MT
04-22	Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating	MT

Evolution of the average Target Price on Ocugen, Inc.

Price target over the last 5 years

History of analyst recommendation changes

727aea2509ae22c8f215f65a224b2.vH3xhsfFteyoSXiQe9g4Val3syKE3DeB73Pbql9jyMo.1TyAzbOXwa3uLB_PIotCZ8c2-2X3sETjvDC-0gwX-6bILcLXtZHlvNgHSA~8bb12b44e3ccabbb224a9932b5cec192

Analyst Recommendations on Ocugen, Inc.

Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating	04-22	MT
Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating	04-22	MT
HC Wainwright Adjusts Price Target on Ocugen to $7 From $5, Maintains Buy Rating	01-24	MT
Cantor Fitzgerald Adjusts Ocugen's Price Target to $2 From $2.50, Keeps Overweight Rating	31/08/23	MT
Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept	08/05/23	MT
Chardan Upgrades Ocugen to Buy From Neutral, Citing Recent Sell-Off	01/03/23	MT
Mizuho Adjusts Price Target on Ocugen to $3 From $5, Maintains Buy Rating	01/03/23	MT
Mizuho Securities Starts Ocugen at Buy With $5 Price Target	23/08/22	MT
HC Wainwright Adjusts Ocugen's Price Target to $6 from $7, Maintains Buy Rating	15/08/22	MT
Roth Capital Reinstates Ocugen at Buy with $8 Price Target	15/06/22	MT
Cantor Fitzgerald Starts Ocugen at Overweight With $4.50 Price Target	02/06/22	MT
Chardan Trims Ocugen's Price Targe to $3.50 From $4, Maintains Neutral Rating	09/05/22	MT
Chardan Research Adjusts Ocugen's Price Target to $3.50 From $4, Maintains Neutral Rating	09/05/22	MT
HC Wainwright Adjusts Ocugen's Price Target to $8 from $10, Maintains Buy Rating	28/02/22	MT
ANALYST RECOMMENDATIONS : Alliant Energy, Ally Financial, Alphabet, HSBC, Honest...	14/06/21
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $4 From $11, Maintains Neutral Rating	11/06/21	MT
OCUGEN : Chardan Adjusts Ocugen PT to $4.50 From $8, Maintains Neutral Rating	11/06/21	MT
OCUGEN : HC Wainwright Adjusts Ocugen's Price Target to $10 From $12, Maintains Buy Rating	11/06/21	MT
OCUGEN : Roth Capital Cuts Ocugen to Neutral From Buy, Price Target to $6 From $10	11/06/21	MT
OCUGEN : Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating	10/05/21	MT
TODAY'S ANALYST RECOMMENDATIONS : Oracle, Facebook, Berkeley, Acushnet, Ocugen, London Stock Exchange, Flutter...	10/05/21
OCUGEN : Cantor Fitzgerald Downgrades Ocugen to Neutral From Overweight, Adjusts PT to $11 From $15	07/05/21	MT
Ocugen : Bharat Biotech Two-Dose COVID-19 Vaccine Candidate Shows 78% Efficacy Rate	21/04/21	MT
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $15 From $4, Maintains Overweight Rating	03/03/21	MT
OCUGEN : Chardan Capital Downgrades Ocugen to Neutral From Buy on Valuation, Adjusts Price Target to $13 From $0.70	09/02/21	MT